A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
This study has been completed.
Sponsor:
ArQule
Information provided by (Responsible Party):
ArQule
ClinicalTrials.gov Identifier:
NCT00777309
First received: October 21, 2008
Last updated: February 22, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | February 6, 2013 |